Work

Thu0189 Efficacy and Safety of Nintedanib in Patients With Autoimmune Disease-related Interstitial Lung Disease Treated With Dmards And/or Glucocorticoids at Baseline

Year: 2020

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2020-eular.3668

Authors: M. Aringer, J. Pope, C. Kelly, A.M. Hoffmann-Vold, J. Belperio, A. James, C. Coeck, M. Quaresma, E. Matteson

Institutions: Technische Universität Dresden, Western University, Newcastle University, Oslo University Hospital, University of California, Los Angeles, Boehringer Ingelheim (Germany), Boehringer Ingelheim (Belgium), Mayo Clinic

Language: English

Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Pfizer, Sanofi Genzyme

OpenAlex ID: W3034202212

Cites:

Cited by: 4

Related to: 10